Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Q32 Bio (QTTB) Operating Margin (2018 - 2023)

Historic Operating Margin for Q32 Bio (QTTB) over the last 6 years, with Q4 2023 value amounting to 1897.72%.

  • Q32 Bio's Operating Margin rose 61987200.0% to 1897.72% in Q4 2023 from the same period last year, while for Sep 2024 it was 5690.07%, marking a year-over-year increase of 63361600.0%. This contributed to the annual value of 725.53% for FY2023, which is 34291100.0% up from last year.
  • According to the latest figures from Q4 2023, Q32 Bio's Operating Margin is 1897.72%, which was up 61987200.0% from 419.47% recorded in Q3 2023.
  • In the past 5 years, Q32 Bio's Operating Margin ranged from a high of 1897.72% in Q4 2023 and a low of 9304.81% during Q1 2019
  • In the last 5 years, Q32 Bio's Operating Margin had a median value of 4145.07% in 2021 and averaged 3582.2%.
  • Its Operating Margin has fluctuated over the past 5 years, first tumbled by -83574300bps in 2019, then skyrocketed by 62023300bps in 2021.
  • Over the past 5 years, Q32 Bio's Operating Margin (Quarter) stood at 4539.79% in 2019, then soared by 33bps to 3041.02% in 2020, then crashed by -38bps to 4192.64% in 2021, then decreased by -3bps to 4301.0% in 2022, then skyrocketed by 144bps to 1897.72% in 2023.
  • Its Operating Margin stands at 1897.72% for Q4 2023, versus 419.47% for Q3 2023 and 226.99% for Q2 2023.